Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FY1F1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,888
Award facts
- Contract value 100% obligated
- $12,887.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors, with a ceiling value of $12,887.98 and an ultimate completion date of October 24, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis, making this procurement consistent with the Defense Health Agency's pharmaceutical supply requirements for military personnel and beneficiaries.
This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The SPE2DX vehicle serves as a comprehensive global pharmaceutical support contract enabling AmerisourceBergen to supply brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. AmerisourceBergen's position as a major pharmaceutical distributor and critical vendor for federal medical procurement demonstrates its capability to fulfill specialized medication requirements through competitive federal contracting processes.
Quick answers
Who was awarded contract SPE2DB26FY1F1?
SPE2DB26FY1F1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FY1F1 worth?
The government has obligated $12,888 on SPE2DB26FY1F1.
Is contract SPE2DB26FY1F1 an order under another contract?
Yes. SPE2DB26FY1F1 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB26FY1F1 competed?
The extent of competition for SPE2DB26FY1F1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award